Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
VolitionRx Limited Announces Strategic Acquisition 2019-12-16 21:30
VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test 2019-12-05 21:30
VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia 2019-12-03 21:30
VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update 2019-11-07 21:30
Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video 2019-10-29 20:30
Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC 2019-10-26 00:00
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas 2019-10-18 20:30
Volition Appoints Dr. Phillip Barnes to Board of Directors 2019-10-10 04:05
Volition Announces Breakthrough in Enrichment of Tumor Nucleosomes 2019-09-17 20:35
Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer 2019-08-08 20:30
VolitionRx Limited Schedules Second Quarter 2019 Earnings Conference Call and Business Update 2019-08-07 20:45
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock 2019-07-25 04:05
VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China 2019-07-18 20:30
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding 2019-07-10 20:30
VolitionRx Limited Schedules First Quarter 2019 Earnings Conference Call and Business Update 2019-05-07 04:05
VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics 2019-04-09 20:30
VolitionRx Limited Signs Memorandum of Understanding with Fosun Long March in China 2019-03-28 22:48
VolitionRx Limited to Present at Conferences in March & April 2019 2019-03-25 20:40
VolitionRx Limited to Present at Conferences in the U.S. Next Week 2019-03-15 20:30
VolitionRx Limited Announces Full Fiscal Year 2018 Financial Results and Business Update 2019-03-14 04:05
1 2 3 4 5 6 7